Dosentrx Ltd.: Clinical Trials

6 trials sponsored by Dosentrx Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 1 completed, 1 suspended. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Unknown 3, Completed 1, Suspended 1

Follow Dosentrx Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Use of ReX to dispense and monitor solid oral medication therapy. - Any Solid Oral Medication
Not applicableUnknownDosentrx Ltd.2002024-03-302025-03-12
Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.
Use of ReX to dispense and monitor solid oral medication therapy. - Any Solid Oral Medication
UnknownDosentrx Ltd.10002024-01-152024-03-28
Evaluation of the ReX-C System, in Patients Receiving CFTR Modulators for the Treatment of Cystic Fibrosis (CF).
ReX-C system - Cystic Fibrosis, Adherence, Medication
Not applicableUnknownDosentrx Ltd.102020-05-122021-09-23
Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics
ReX-C system - Oncology, Adherence, Medication
Not applicableSuspendedDosentrx Ltd.202020-04-212021-09-20
Evaluation of ReX-C System in Measurement and Improvement of Patients' Adherence.
ReX-C intervention, Standard of Care - Thromboembolism
Not applicableUnknownDosentrx Ltd.1002019-01-092023-12-12
Evaluation of Oral PCA Device - PCoA™ Acute
patients receiving oral analgesics via the PCoA™ Acute - Pain, Postoperative
Not applicableCompletedDosentrx Ltd.702015-06-012017-05-08

Conditions studied

Medication Adherence (2)  ·  Cystic Fibrosis (1)  ·  Neoplasms (1)  ·  Pain, Postoperative (1)  ·  Thromboembolism (1)

Interventions

Standard of Care (1)

Countries

Israel (3)  ·  United States (2)

Top investigators

David Shoseyyov, MD (1)  ·  David Waterhouse, MD (1)  ·  Galit Livnat-Levanon, MD (1)  ·  Meir Preis, MD (1)  ·  Ravit Geva, MD (1)